Skip to main content

Animations

MJFF Publications

1 - 10 of 8137 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • OPEN
    Title: Prioritizing Parkinson’s disease risk genes in genome-wide association loci
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00933-0
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson’s disease-like neurodegeneration
    Journal Name: Fluids and Barriers of the CNS
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s12987-025-00646-9
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaques
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00938-9
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Astrocytic RNA editing regulates the host immune response to alpha-synuclein
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adp8504
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adq2519
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41467-025-58585-w
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1186/s40478-025-01988-z
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00919-y
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Characterization of Isolated Human Astrocytes from Aging Brain
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/ijms26073416
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Hyposmia in Parkinson’s disease; exploring selective odour loss
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00922-3
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.